Ant2 Protein T Cell Cancer Breakthrough: Scientists Just Rewired the Immune System to Fight Tumors

# Ant2 Protein T Cell Cancer Breakthrough: Scientists Just Rewired the Immune System to Fight Tumors

> **Quick answer:** Researchers at Hebrew University of Jerusalem found that blocking the Ant2 protein forces T cells — the immune system's cancer-killing soldiers — to completely rewire how they produce energy. This metabolic shift makes them faster, more durable, and significantly better at destroying tumors. Crucially, the effect can be triggered with drugs, not just genetic modifications, opening a real path to clinical treatment.

Scientists have just identified a single molecular switch that, when blocked, transforms ordinary immune cells into highly effective cancer-fighting machines. The discovery centers on a protein called Ant2, and a new 2025 study published in *Nature Communications* shows that disabling it triggers a cascade of metabolic changes that supercharge T cells — the immune system's primary weapon against cancer.

*This article is for informational purposes only and does not replace professional medical advice. Consult a healthcare provider for medical concerns.*

## What Is the Ant2 Protein and Why Does Blocking It Matter?

Ant2 — formally known as ADP/ATP translocase-2 — is a protein that sits inside the mitochondria, the energy-generating compartments of cells. Its usual job is straightforward: shuttling ATP (the cell's energy currency) out of the mitochondria and bringing in ADP for recharging.